Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,532,084
+$11,532,084 QoQ
Shares Held
73,584
Ownership
0.004%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#159
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$9,878,342
PutShares
64,670
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOGAN CAPITAL MANAGEMENT INC holds $143,017,458 across 13 Drug Manufacturers - General names. NVS ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,791 | $33,333,361 | |
| 2 | MRK |
Merck & Co., Inc.
|
155,292 | $19,955,022 | |
| 3 | ABBV |
AbbVie Inc.
|
77,182 | $19,422,078 | |
| 4 | JNJ |
Johnson & Johnson
|
62,551 | $15,886,077 | |
| 5 | NVS |
Novartis AG
This page
|
73,584 | $11,532,084 | |
| 6 | SNY |
Sanofi
|
258,642 | $11,033,667 | |
| 7 | PFE |
Pfizer Inc
|
442,396 | $10,652,895 | |
| 8 | GSK |
GSK plc
|
141,076 | $7,395,203 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,532,084 | 73,584 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,878,342 | 64,670 | Put | Sole | 2026-05-08 | |
| 2025-12-31 | $8,046,506 | 58,363 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,707,593 | 52,305 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,646,326 | 46,660 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $4,677,589 | 41,959 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $4,026,785 | 41,381 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,696,956 | 40,836 | Shares | Sole | 2024-12-06 | |
| 2024-06-30 | $4,166,205 | 39,134 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,932,558 | 40,655 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,579,083 | 35,447 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,450,914 | 33,879 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,865,054 | 38,302 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,620,936 | 39,358 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,559,943 | 39,241 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,868,085 | 37,733 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,916,538 | 34,503 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,634,342 | 30,021 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,466,566 | 28,199 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,957,158 | 23,932 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,191,949 | 24,024 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $1,769,350 | 20,699 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,903,425 | 20,157 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,826,420 | 21,003 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,720,859 | 19,703 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,559,046 | 18,909 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||